Telomir Pharmaceuticals, Inc.

8.15 USD
+0.16 (+2.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Telomir Pharmaceuticals, Inc. stock is up 25.58% since 30 days ago. The next earnings date is May 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 1 April’s closed higher than March.

About Telomir Pharmaceuticals, Inc.

We are a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. Our corporate headquarters is located at 855 N Wolfe Street, Suite 601, Baltimore, Maryland.